SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-144484
Filing Date
2024-05-22
Accepted
2024-05-22 08:23:34
Documents
15
Period of Report
2024-05-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d815433d8k.htm   iXBRL 8-K 25966
2 EX-99.1 d815433dex991.htm EX-99.1 7420
6 GRAPHIC g815433dsp1.jpg GRAPHIC 9098
  Complete submission text file 0001193125-24-144484.txt   168184

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crnx-20240522.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20240522_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20240522_pre.xml EX-101.PRE 10816
18 EXTRACTED XBRL INSTANCE DOCUMENT d815433d8k_htm.xml XML 3510
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 24971681
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)